Mr. Asensio warned in a September article in this newspaper that ErgoBilt faced problems. He views "it as a terminal short," meaning he believes that stock will soon be worth nothing. (ErgoBilt stock soon became worthless.)

Jonathan Weil. The Wall Street Journal

Other resources of interest

A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio
 
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
Manuel Asensio Report: Jan. 14, 2004 Business as usual at PolyMedica.
Manuel Asensio and Asensio.com ("Asensio") report that yesterday PolyMedica Corporation (NASDAQ: PLMD, $26.62) announced that Stephen C. Farrell was named President of Liberty Healthcare Group to replace W. Keith Trowbridge who resigned effective immediately. Prior to his employment at PolyMedica, Mr. Trowbridge was an officer of Transworld Healthcare, Inc., T2 Medical and Medical Associates of America. Transworld and T2 each faced Medicare fraud allegations and Medical Associates declared bankruptcy after Mr. Trowbridge left. During the five years that Mr. Trowbridge was employed by PolyMedica, quarterly sales grew from $30.6 million to $105.2 million and quarterly EBITDA grew from $4.8 million to $23.4 million. Clearly a lack of generating revenue growth and earnings growth were not the reasons for Mr. Trowbridge's departure. The belief of Manuel Asensio and Asensio is that Mr. Trowbridge's departure is merely the latest shallow attempt by PolyMedica to appease government prosecutors. Manuel Asensio and Asensio see no reason whatsoever to believe that this latest management change can in any way reduce the magnitude of PolyMedica's incurred liabilities that result from its alleged criminal conduct. Manuel Asensio and Asensio simply see no ability for PolyMedica to operate profitably without abusing the Medicare system and its beneficiaries.
 
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
© 2010 Asensioexposes!com offers accurate facts that disproves past criticism of the Manuel Asensio Reports. Web Directory
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.